Court: | nyed |
Docket #: | 2:17-cv-01837 |
Case Name: | Altaire Pharmaceuticals, Inc. et al v. Paragon BioTeck, Inc. |
PACER case #: | 399530 |
Date filed: | 2017-03-31 |
Case Cause: | 28:1331 Fed. Question |
Nature of Suit: | 830 Patent |
Jury Demand: | Plaintiff |
Jurisdiction: | Federal Question |
Represented Party | Attorney & Contact Info |
Altaire Pharmaceuticals, Inc. Plaintiff |
Michael Frank Autuoro |
Assad Sawaya Plaintiff |
Michael Frank Autuoro |
Paragon BioTeck, Inc. Defendant |
Date Filed | Document # | Attachment # | Short Description | Long Description | Upload date | SHA1 hash |
2017-04-03 | 1 | 0 | COMPLAINT against Paragon BioTeck, Inc. filing fee $ 400, receipt number 0207-9419289 Was the Disclosure Statement on Civil Cover Sheet completed -YES,, filed by Altaire Pharmaceuticals, Inc., Assad Sawaya. (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H, # 11 Exhibit I, # 12 Exhibit J, # 13 Exhibit K, # 14 Exhibit L, # 15 Exhibit M, # 16 Exhibit N) (Autuoro, Michael) (Entered: 04/03/2017) | |||
2017-04-03 | 2 | 0 | Corporate Disclosure Statement by Altaire Pharmaceuticals, Inc. (Autuoro, Michael) (Entered: 04/03/2017) |